Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...